Vilnius University Hospital Santaros Klinikos in Vilnius, Lithuania is a teaching hospital of the Vilnius University Faculty of Medicine. Santaros Klinikos is co-funded by the Lithuanian Ministry of Health and Vilnius University.

During the past decade, Vilnius University Hospital Santaros klinikos conducted 102 clinical trials. In the 10-year time frame, 102 clinical trials started and 35 clinical trials were completed, i.e. on average, 34.3% percent of trials that started reached the finish line to date. In the past 5 years, 55 clinical trials started and 24 clinical trials were completed. i.e. 43.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Vilnius University Hospital Santaros klinikos" #1 sponsor was "Vilnius University" with 15 trials, followed by "Bayer" with 9 trials sponsored, "Eli Lilly and Company" with 5 trials sponsored, "Hoffmann-La Roche" with 5 trials sponsored and "Shire" with 5 trials sponsored. Other sponsors include 88 different institutions and companies that sponsored additional 74 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Vilnius University Hospital Santaros klinikos" #1 collaborator was "Vilnius University Hospital Santaros Klinikos" with 4 trials as a collaborator, "MLM Medical Labs GmbH" with 3 trials as a collaborator, "Massachusetts General Hospital" with 3 trials as a collaborator, "nabios GmbH" with 3 trials as a collaborator and "Dermira, Inc." with 2 trials as a collaborator. Other collaborators include 165 different institutions and companies that were collaborators in the rest 172 trials.

According to Clinical.Site data, the most researched conditions in "Vilnius University Hospital Santaros klinikos" are "Ulcerative Colitis" (8 trials), "Atrial Fibrillation" (4 trials), "Crohn's Disease" (4 trials), "Mitral Regurgitation" (4 trials) and "Atrioventricular Block" (3 trials). Many other conditions were trialed in "Vilnius University Hospital Santaros klinikos" in a lesser frequency.

Most popular intervention types in "Vilnius University Hospital Santaros klinikos" are "Drug" (76 trials), "Device" (24 trials), "Other" (18 trials), "Biological" (10 trials) and "Procedure" (8 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (37 trials), "Ontamalimab" (4 trials), "Ozanimod" (3 trials), "Apixaban" (2 trials) and "CABG" (2 trials). Other intervention names were less common.

The vast majority of trials in "Vilnius University Hospital Santaros klinikos" are 123 trials for "All" genders, 5 trials for "Male" genders and 4 trials for "Female" genders.

Currently, there are NaN active trials in "Vilnius University Hospital Santaros klinikos". undefined are not yet recruiting, 32 are recruiting, 19 are Active, not recruiting, and 6 are Enrolling by invitation. In total, there were 50 completed trials in Vilnius University Hospital Santaros klinikos, undefined suspended trials, and 15 terminated clinical trials to date.

Out of the total trials that were conducted in Vilnius University Hospital Santaros klinikos, 5 "Phase 1" clinical trials were conducted, 19 "Phase 2" clinical trials and 61 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 30 trials that are defined as “Not Applicable".

Vilnius University Hospital Santaros klinikos has several departments that took part in Clinical trials: "Vilnius University Hospital Santariskiu Clinic, Public Institution; Cardiology" - 3 trials, "Vilnius University Hospital Santariskiu Clinic, Hematology, Oncology and Tranfusion Medicine Center" - 3 trials, "Rare diseases coordinating centre, Vilnius University Hospital Santaros klinikos" - 2 trials, "Vilnius University Hospital Santariskiu Clinics; Neurology" - 2 trials